CA2370646A1 - Immunisation de l'acide nucleique - Google Patents
Immunisation de l'acide nucleique Download PDFInfo
- Publication number
- CA2370646A1 CA2370646A1 CA002370646A CA2370646A CA2370646A1 CA 2370646 A1 CA2370646 A1 CA 2370646A1 CA 002370646 A CA002370646 A CA 002370646A CA 2370646 A CA2370646 A CA 2370646A CA 2370646 A1 CA2370646 A1 CA 2370646A1
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- use according
- sequence
- particles
- polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention porte sur des molécules d'acide nucléique de recombinaison. Les molécules possèdent une première séquence codant un peptide qui stimule un antigène cible. L'invention porte également sur des réactifs tels que des vecteurs et sur des compositions contenant ces molécules; sur des procédés de construction de ces réactifs et sur des procédés d'utilisation de ces réactifs pour déclencher une réponse immunitaire.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13024999P | 1999-04-21 | 1999-04-21 | |
US60/130,249 | 1999-04-21 | ||
PCT/US2000/010766 WO2000063385A2 (fr) | 1999-04-21 | 2000-04-21 | Immunisation de l'acide nucleique |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2370646A1 true CA2370646A1 (fr) | 2000-10-26 |
Family
ID=22443785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002370646A Abandoned CA2370646A1 (fr) | 1999-04-21 | 2000-04-21 | Immunisation de l'acide nucleique |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1180150A2 (fr) |
JP (1) | JP2002542264A (fr) |
AU (1) | AU4479700A (fr) |
CA (1) | CA2370646A1 (fr) |
NZ (1) | NZ515041A (fr) |
WO (1) | WO2000063385A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004535358A (ja) * | 2000-11-02 | 2004-11-25 | パウダージェクト ワクチンズ,インコーポレーテッド | 核酸免疫 |
CN1842349A (zh) * | 2003-08-29 | 2006-10-04 | 安琪士摩奇株式会社 | 使用无针注射器进行皮肤疾病基因治疗 |
WO2006027244A2 (fr) * | 2004-09-10 | 2006-03-16 | Bracco Imaging S.P.A. | Complexes metalliques paramagnetiques pour la visualisation en irm de polynucleotides internalises |
WO2006133497A1 (fr) * | 2005-06-15 | 2006-12-21 | Adelaide Research & Innovation Pty Ltd | Traitement combiné |
WO2007087758A2 (fr) * | 2006-01-31 | 2007-08-09 | Centro De Ingenieria Genetica Y Biotecnologia | Mimotopes de polysaccharides capsulaires de neisseria meningitidis et leurs formulations pharmaceutiques |
EP3590503A1 (fr) | 2006-10-12 | 2020-01-08 | The University of Queensland | Compositions et procédés pour moduler les réponses immunologiques |
BR112013010926A2 (pt) | 2010-11-01 | 2016-08-23 | Univ Technology Sidney | agentes imunomoduladores e seus usos |
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
MX2020007246A (es) | 2017-10-13 | 2020-11-13 | Univ New York State Res Found | Diseño de vacuna integral para el avance de enfermedad comensal. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1624068A1 (fr) * | 1993-06-01 | 2006-02-08 | Life Technologies Inc. | Vaccination génétique avec des lipides cationiques |
WO1995019799A1 (fr) * | 1994-01-21 | 1995-07-27 | Agracetus, Inc. | Instrument de depot de genes par entrainement gazeux |
HUP9802651A3 (en) * | 1995-09-28 | 2001-08-28 | Univ Pittsburgh | Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
GB9609125D0 (en) * | 1996-05-01 | 1996-07-03 | Smithkline Beecham Plc | Novel compounds |
US6204250B1 (en) * | 1996-11-22 | 2001-03-20 | The Mount Sinai Medical Center Of The City Of New York | Immunization of infants |
-
2000
- 2000-04-21 JP JP2000612464A patent/JP2002542264A/ja not_active Withdrawn
- 2000-04-21 CA CA002370646A patent/CA2370646A1/fr not_active Abandoned
- 2000-04-21 AU AU44797/00A patent/AU4479700A/en not_active Abandoned
- 2000-04-21 EP EP00926234A patent/EP1180150A2/fr not_active Withdrawn
- 2000-04-21 WO PCT/US2000/010766 patent/WO2000063385A2/fr not_active Application Discontinuation
- 2000-04-21 NZ NZ515041A patent/NZ515041A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NZ515041A (en) | 2004-03-26 |
WO2000063385A3 (fr) | 2001-02-22 |
WO2000063385A2 (fr) | 2000-10-26 |
AU4479700A (en) | 2000-11-02 |
JP2002542264A (ja) | 2002-12-10 |
EP1180150A2 (fr) | 2002-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ellis | New technologies for making vaccines | |
ES2670196T3 (es) | Disolución de polisacáridos capsulares y vacunas de combinación | |
EP1221968B1 (fr) | Procede d'obtention de reponses immunes cellulaires de proteines | |
ES2523365T3 (es) | Expresión híbrida y en tandem de proteínas de Neisseria | |
JP5670003B2 (ja) | 血清型BおよびC由来のNeisseriameningitidis抗原、ならびにさらなる抗原を含む組成物 | |
BRPI0609460A2 (pt) | haemophilus influenzae tipo b | |
JP4646516B2 (ja) | 吸着したポリペプチド含有分子を有する微粒子 | |
MXPA01009452A (es) | Vacuna. | |
US20070042050A1 (en) | Nucleic acid vaccine compositions having a mammalian CD80/CD86 gene promoter driving antigen expression | |
CA2370646A1 (fr) | Immunisation de l'acide nucleique | |
EP1379273B1 (fr) | Adjuvants comportant des acides nucleiques | |
ZA200503377B (en) | Nucleic acid constructs for gene expression | |
AU2001297988A1 (en) | Nucleic acid adjuvants | |
US20070237789A1 (en) | DNA-vaccines based on constructs derived from the genomes of human and animal pathogens | |
US8034349B2 (en) | Peptides that mimic non-human cross-reactive protective epitopes of the group B meningococcal capsular polysaccharide | |
US20040082530A1 (en) | Nucleic acid immunization | |
US20060019921A1 (en) | Nucleic acid adjuvants | |
US20050148529A1 (en) | Nucleic acid immunization | |
AU785066B2 (en) | DNA-vaccines based on constructs derived from the genomes of human and animal pathogens | |
WO2001083528A2 (fr) | Immunisation au moyen d'acide nucleique | |
JP2004522403A (ja) | 抗原発現を駆動する哺乳動物cd80/cd86遺伝子プロモーターを有する核酸ワクチン組成物 | |
MXPA01009455A (en) | Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |